Skip to main content
OpenTrials
Completed

NCT Number: NCT01352897

Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

The objective of this follow-up retrospective study is to evaluate the long term efficacy and safety of rosuvastatin in reducing lipid parameters in clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypercholesterolaemia Dyslipidemias Hypercholesterolemia Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site

Singapore

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary hypercholesterolemia
  • Subjects from first rosuvastatin Registry study

Treatment and study plan

Primary outcomes

  1. Percentage of patients who maintain US NCEP ATP III LDL-C target goals after long-term therapy

    Time frame: Up to 8 years

Secondary outcomes

  1. LDL-cholesterol levels

    Time frame: Up to 8 years

  2. HDL-cholesterol levels

    Time frame: Up to 8 years

  3. Proportion of patients having raised levels of serum CK or ALT

    Time frame: Up to 8 years

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects With Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
May 12, 2011
Registry last updated
May 12, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.